10 new Hepatitis C Articles

[Guest guest]

News

10 new results for Hepatitis

Bristol-Myers Interferon-Free Mixture Cures Hepatitis-C Patients in Study

Bloomberg

(BMY)'s cocktail of two experimental drugs cured four hepatitis C patients in

the first success for a therapy that excludes often-toxic existing drugs. The

combination had a higher rate of success when paired with the current standard

treatment in the ...

See all stories on this topic »

New drug may boost hepatitis C treatment

USA Today

By Reinberg HealthDay Adding the new drug boceprevir to the current

two-drug treatment for hepatitis C appears significantly more effective than the

standard therapy, according to two new studies. The drugs now used to treat

hepatitis C, ...

See all stories on this topic »

Possible cure for hepatitis C promising

UPI.com

BERLIN, April 2 (UPI) -- Drugs used to treat hepatitis C that previously failed

were more successful using different parameters, researchers at a conference in

Germany say. Professor Heiner Wedemeyer, secretary-general of the European

Association for ...

See all stories on this topic »

Hepatitis C drugs could cure disease

Shreveport Times

" We're closing in on a cure, " said Dr. Stuart Gordon, a hepatitis C researcher

at Henry Ford Hospital here. Gordon coauthored one of the drug studies,

appearing in Thursday's New England Journal of Medicine. The cocktails consist

of two new drugs: ...

See all stories on this topic »

Sadie Frost, Boy and Moorish raise £10000 for the Hepatitis C Trust

Mirror.co.uk

Hepatitis C event at London's Jazz Cafe, and she told me she's just enjoyed a

truly relaxing holiday in Kerala with her kids. “India's heavenly, I was the

most relaxed ever,” she said. “I tweeted saying I have never been so in love and

everyone thought ...

See all stories on this topic »

Mirror.co.uk

DEB025 a New Drug for Hepatitis C

French Tribune

A study involving around 300 untreated patients infected with the most common

form of hepatitis C virus (HCV), the genotype 1 (G1) has revealed that drug

DEB025 is more effective in treating Hepatitis C. The findings have shown that

as compared to 55% ...

See all stories on this topic »

French Tribune

Boehringer Ingelheim's lead hepatitis C compound moves into Phase III – the ...

Vancouver Sun

“We are committed to bringing BI 201335 forward, with the ambition of improving

cure rates for the benefit of those living with hepatitis C.” BI 201335 will be

evaluated in multiple randomised, double-blind, placebo-controlled trials in

combination ...

See all stories on this topic »

Promissing Advances against Hepatitis C

HD Newsroom

Dr. Stuart Gordon of Henry Ford Hospital in Detroit said the encouraging results

of a clinical study he conducted with his colleagues could quickly lead to a new

standard treatment for patients suffering from hepatitis C. The results of this

survey of ...

See all stories on this topic »

Bristol-Myers' Compound Shows Higher Response Rate In Phase 2b Hepatitis C Study

RTT News

The EMERGE study is a two-part, randomized, controlled, multicenter, phase II

study of PEG-Interferon lambda in 526 treatment-naïve patients with chronic

hepatitis C genotype 1, 2, 3 or 4. Part one of EMERGE was a Phase IIa study, and

results were ...

See all stories on this topic »

Trailer for Don't Bleed On Me Documentary Released

411mania.com

The trailer for a new documentary - Don't Bleed On Me - Wrestling's Hepatitis C

Secret Revealed has been released on YouTube just in time for WrestleMania XXVII

weekend. The film tells the story of Devon " Hannibal " Nicholson, a Canadian

wrestler who ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.

[Guest guest]

News

10 new results for Hepatitis

Bristol-Myers Interferon-Free Mixture Cures Hepatitis-C Patients in Study

Bloomberg

(BMY)'s cocktail of two experimental drugs cured four hepatitis C patients in

the first success for a therapy that excludes often-toxic existing drugs. The

combination had a higher rate of success when paired with the current standard

treatment in the ...

See all stories on this topic »

New drug may boost hepatitis C treatment

USA Today

By Reinberg HealthDay Adding the new drug boceprevir to the current

two-drug treatment for hepatitis C appears significantly more effective than the

standard therapy, according to two new studies. The drugs now used to treat

hepatitis C, ...

See all stories on this topic »

Possible cure for hepatitis C promising

UPI.com

BERLIN, April 2 (UPI) -- Drugs used to treat hepatitis C that previously failed

were more successful using different parameters, researchers at a conference in

Germany say. Professor Heiner Wedemeyer, secretary-general of the European

Association for ...

See all stories on this topic »

Hepatitis C drugs could cure disease

Shreveport Times

" We're closing in on a cure, " said Dr. Stuart Gordon, a hepatitis C researcher

at Henry Ford Hospital here. Gordon coauthored one of the drug studies,

appearing in Thursday's New England Journal of Medicine. The cocktails consist

of two new drugs: ...

See all stories on this topic »

Sadie Frost, Boy and Moorish raise £10000 for the Hepatitis C Trust

Mirror.co.uk

Hepatitis C event at London's Jazz Cafe, and she told me she's just enjoyed a

truly relaxing holiday in Kerala with her kids. “India's heavenly, I was the

most relaxed ever,” she said. “I tweeted saying I have never been so in love and

everyone thought ...

See all stories on this topic »

Mirror.co.uk

DEB025 a New Drug for Hepatitis C

French Tribune

A study involving around 300 untreated patients infected with the most common

form of hepatitis C virus (HCV), the genotype 1 (G1) has revealed that drug

DEB025 is more effective in treating Hepatitis C. The findings have shown that

as compared to 55% ...

See all stories on this topic »

French Tribune

Boehringer Ingelheim's lead hepatitis C compound moves into Phase III – the ...

Vancouver Sun

“We are committed to bringing BI 201335 forward, with the ambition of improving

cure rates for the benefit of those living with hepatitis C.” BI 201335 will be

evaluated in multiple randomised, double-blind, placebo-controlled trials in

combination ...

See all stories on this topic »

Promissing Advances against Hepatitis C

HD Newsroom

Dr. Stuart Gordon of Henry Ford Hospital in Detroit said the encouraging results

of a clinical study he conducted with his colleagues could quickly lead to a new

standard treatment for patients suffering from hepatitis C. The results of this

survey of ...

See all stories on this topic »

Bristol-Myers' Compound Shows Higher Response Rate In Phase 2b Hepatitis C Study

RTT News

The EMERGE study is a two-part, randomized, controlled, multicenter, phase II

study of PEG-Interferon lambda in 526 treatment-naïve patients with chronic

hepatitis C genotype 1, 2, 3 or 4. Part one of EMERGE was a Phase IIa study, and

results were ...

See all stories on this topic »

Trailer for Don't Bleed On Me Documentary Released

411mania.com

The trailer for a new documentary - Don't Bleed On Me - Wrestling's Hepatitis C

Secret Revealed has been released on YouTube just in time for WrestleMania XXVII

weekend. The film tells the story of Devon " Hannibal " Nicholson, a Canadian

wrestler who ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.

[Guest guest]

News

10 new results for Hepatitis

Bristol-Myers Interferon-Free Mixture Cures Hepatitis-C Patients in Study

Bloomberg

(BMY)'s cocktail of two experimental drugs cured four hepatitis C patients in

the first success for a therapy that excludes often-toxic existing drugs. The

combination had a higher rate of success when paired with the current standard

treatment in the ...

See all stories on this topic »

New drug may boost hepatitis C treatment

USA Today

By Reinberg HealthDay Adding the new drug boceprevir to the current

two-drug treatment for hepatitis C appears significantly more effective than the

standard therapy, according to two new studies. The drugs now used to treat

hepatitis C, ...

See all stories on this topic »

Possible cure for hepatitis C promising

UPI.com

BERLIN, April 2 (UPI) -- Drugs used to treat hepatitis C that previously failed

were more successful using different parameters, researchers at a conference in

Germany say. Professor Heiner Wedemeyer, secretary-general of the European

Association for ...

See all stories on this topic »

Hepatitis C drugs could cure disease

Shreveport Times

" We're closing in on a cure, " said Dr. Stuart Gordon, a hepatitis C researcher

at Henry Ford Hospital here. Gordon coauthored one of the drug studies,

appearing in Thursday's New England Journal of Medicine. The cocktails consist

of two new drugs: ...

See all stories on this topic »

Sadie Frost, Boy and Moorish raise £10000 for the Hepatitis C Trust

Mirror.co.uk

Hepatitis C event at London's Jazz Cafe, and she told me she's just enjoyed a

truly relaxing holiday in Kerala with her kids. “India's heavenly, I was the

most relaxed ever,” she said. “I tweeted saying I have never been so in love and

everyone thought ...

See all stories on this topic »

Mirror.co.uk

DEB025 a New Drug for Hepatitis C

French Tribune

A study involving around 300 untreated patients infected with the most common

form of hepatitis C virus (HCV), the genotype 1 (G1) has revealed that drug

DEB025 is more effective in treating Hepatitis C. The findings have shown that

as compared to 55% ...

See all stories on this topic »

French Tribune

Boehringer Ingelheim's lead hepatitis C compound moves into Phase III – the ...

Vancouver Sun

“We are committed to bringing BI 201335 forward, with the ambition of improving

cure rates for the benefit of those living with hepatitis C.” BI 201335 will be

evaluated in multiple randomised, double-blind, placebo-controlled trials in

combination ...

See all stories on this topic »

Promissing Advances against Hepatitis C

HD Newsroom

Dr. Stuart Gordon of Henry Ford Hospital in Detroit said the encouraging results

of a clinical study he conducted with his colleagues could quickly lead to a new

standard treatment for patients suffering from hepatitis C. The results of this

survey of ...

See all stories on this topic »

Bristol-Myers' Compound Shows Higher Response Rate In Phase 2b Hepatitis C Study

RTT News

The EMERGE study is a two-part, randomized, controlled, multicenter, phase II

study of PEG-Interferon lambda in 526 treatment-naïve patients with chronic

hepatitis C genotype 1, 2, 3 or 4. Part one of EMERGE was a Phase IIa study, and

results were ...

See all stories on this topic »

Trailer for Don't Bleed On Me Documentary Released

411mania.com

The trailer for a new documentary - Don't Bleed On Me - Wrestling's Hepatitis C

Secret Revealed has been released on YouTube just in time for WrestleMania XXVII

weekend. The film tells the story of Devon " Hannibal " Nicholson, a Canadian

wrestler who ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.

[Guest guest]

News

10 new results for Hepatitis

Bristol-Myers Interferon-Free Mixture Cures Hepatitis-C Patients in Study

Bloomberg

(BMY)'s cocktail of two experimental drugs cured four hepatitis C patients in

the first success for a therapy that excludes often-toxic existing drugs. The

combination had a higher rate of success when paired with the current standard

treatment in the ...

See all stories on this topic »

New drug may boost hepatitis C treatment

USA Today

By Reinberg HealthDay Adding the new drug boceprevir to the current

two-drug treatment for hepatitis C appears significantly more effective than the

standard therapy, according to two new studies. The drugs now used to treat

hepatitis C, ...

See all stories on this topic »

Possible cure for hepatitis C promising

UPI.com

BERLIN, April 2 (UPI) -- Drugs used to treat hepatitis C that previously failed

were more successful using different parameters, researchers at a conference in

Germany say. Professor Heiner Wedemeyer, secretary-general of the European

Association for ...

See all stories on this topic »

Hepatitis C drugs could cure disease

Shreveport Times

" We're closing in on a cure, " said Dr. Stuart Gordon, a hepatitis C researcher

at Henry Ford Hospital here. Gordon coauthored one of the drug studies,

appearing in Thursday's New England Journal of Medicine. The cocktails consist

of two new drugs: ...

See all stories on this topic »

Sadie Frost, Boy and Moorish raise £10000 for the Hepatitis C Trust

Mirror.co.uk

Hepatitis C event at London's Jazz Cafe, and she told me she's just enjoyed a

truly relaxing holiday in Kerala with her kids. “India's heavenly, I was the

most relaxed ever,” she said. “I tweeted saying I have never been so in love and

everyone thought ...

See all stories on this topic »

Mirror.co.uk

DEB025 a New Drug for Hepatitis C

French Tribune

A study involving around 300 untreated patients infected with the most common

form of hepatitis C virus (HCV), the genotype 1 (G1) has revealed that drug

DEB025 is more effective in treating Hepatitis C. The findings have shown that

as compared to 55% ...

See all stories on this topic »

French Tribune

Boehringer Ingelheim's lead hepatitis C compound moves into Phase III – the ...

Vancouver Sun

“We are committed to bringing BI 201335 forward, with the ambition of improving

cure rates for the benefit of those living with hepatitis C.” BI 201335 will be

evaluated in multiple randomised, double-blind, placebo-controlled trials in

combination ...

See all stories on this topic »

Promissing Advances against Hepatitis C

HD Newsroom

Dr. Stuart Gordon of Henry Ford Hospital in Detroit said the encouraging results

of a clinical study he conducted with his colleagues could quickly lead to a new

standard treatment for patients suffering from hepatitis C. The results of this

survey of ...

See all stories on this topic »

Bristol-Myers' Compound Shows Higher Response Rate In Phase 2b Hepatitis C Study

RTT News

The EMERGE study is a two-part, randomized, controlled, multicenter, phase II

study of PEG-Interferon lambda in 526 treatment-naïve patients with chronic

hepatitis C genotype 1, 2, 3 or 4. Part one of EMERGE was a Phase IIa study, and

results were ...

See all stories on this topic »

Trailer for Don't Bleed On Me Documentary Released

411mania.com

The trailer for a new documentary - Don't Bleed On Me - Wrestling's Hepatitis C

Secret Revealed has been released on YouTube just in time for WrestleMania XXVII

weekend. The film tells the story of Devon " Hannibal " Nicholson, a Canadian

wrestler who ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.